Guardant Health (GH) announced that a jury in the U.S. District Court for the Northern District of California unanimously found in favor of Guardant Health on all of its claims
Guardant Health (GH) announced that a jury in the U.S. District Court for the Northern District of California unanimously found in favor of Guardant Health on all of its claims
Natera (NTRA) issued the following statement: “In 2021, Natera and Guardant Health (GH) filed false advertising cases against each other concerning statements both companies made more than three years ago
Piper Sandler raised the firm’s price target on Natera (NTRA) to $200 from $150 following quarterly results. The firm keeps an Overweight rating on the shares. Published first on TheFly
הפירמה ממשיכים להחזיק בדירוג קנייה למניות.
Puneet Souda, an analyst from Leerink Partners, maintained the Buy rating on Natera (NTRA – Research Report). The associated price target was raised to $185.00. Puneet Souda has given his